United Therapeutics Director Sells 42K Shares and 4 Insider Sales to Note

Sullivan Louis W who is Director at United Therapeutics Corp. (NASDAQ:UTHR), sold 42,000 shares at $78.48 per share for a total value of $3,296,122. The shares recently traded at $82.28, up $3.8, or 4.84% since the insider sale.

UTHR 20131002

Morton Marshall N who is Vice Chairman at Media General, Inc. (NYSE:MEG), sold 34,303 shares at $14.00 per share for a total value of $480,259. The shares recently traded at $14.38, up $0.38, or 2.71% since the insider sale.

MEG 20131002

Froude Donald E who is Pres., Personal Advisors Group at Ameriprise Financial Inc. (NYSE:AMP), sold 6,500 shares at $91.15 per share for a total value of $592,463. The shares recently traded at $92.18, up $1.03, or 1.13% since the insider sale.

AMP 20131002

Mccreary James C who is VP and Corp. Controller at HB Fuller Co. (NYSE:FUL), sold 8,835 shares at $45.24 per share for a total value of $399,664. The shares recently traded at $45.95, up $0.71, or 1.57% since the insider sale.

FUL 20131002

Flanagan Glenda J who is Director at Credit Acceptance Corp. (NASDAQ:CACC), sold 10,000 shares at $110.47 per share for a total value of $1,104,679. The shares recently traded at $111, up $0.53, or 0.48% since the insider sale.

CACC 20131002

Don’t Miss: These 4 Stocks Dodged the Government Shutdown Drama.

More Articles About:    

More from The Cheat Sheet